Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (122)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
483 result(s) found, displaying 351 to 375
-
Market actions
-
Safety alertsYong Gang tablets contain undeclared prescription substances and pose serious health risks. Stop using them and return any remaining tablets to your pharmacy. Consult your doctor if you have concerns.
-
Safety alerts
-
-
Safety alertsThe TGA has issued updated safety advice for health professionals regarding dabigatran (Pradaxa), highlighting the increased risk of bleeding and the importance of careful patient selection and monitoring, especially in older adults and those with kidney impairment.
-
Safety alertsTGA has issued updated safety advice for consumers taking Pradaxa (dabigatran), highlighting risks such as bleeding and the importance of proper storage and patient monitoring.
-
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
-
Safety alerts
-
Safety alertsAbout seasonal flu vaccine: 2013 seasonal influenza vaccines for use in children
-
Safety alerts
-
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Market actionsWe are recalling all batches of Muscletech Hydroxystim capsules due to the presence of the banned substance DMAA. Consult your doctor if you have concerns.